A Short Cycle of Narrow-Band UVB Phototherapy in the Early Phase of Dupilumab Therapy Can Provide a Quicker Improvement of Severe Atopic Dermatitis
Academic Article
Publication Date:
2021
Abstract:
Since the best clinical response to dupilumab is achieved after 12-16 weeks, a combination therapy at the beginning of the treatment could be a helpful strategy to reach a faster response in patients with severe atopic dermatitis (AD).
CRIS type:
1.1 Articolo in rivista
Keywords:
Atopic dermatitis; Dupilumab; Narrow-band UVB phototherapy
List of contributors:
Rossi, Mariateresa; Rovati, Chiara; Arisi, Mariachiara; Tomasi, Cesare; Calzavara-Pinton, Irene; Venturini, Marina; Calzavara-Pinton, Piergiacomo
Published in: